Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial

The quality of VKA management as measured by TTR correlates with the occurrence of non-surgical bleeding in patients with the HM3 LVAD, with a lower TTR associated with an increased bleeding risk. These data provide new clinical direction to define a benchmark TTR to achieve further mitigation of residual risk of bleeding and enhance haemocompatibility with the HM3 LVAD.

Authors

Institutions

Publication Details

Journal
European Heart Journal
Published
2025-11-07
DOI
https://doi.org/10.1093/eurheartj/ehaf745
Citations
4
Primary Topic
Mechanical Circulatory Support Devices
Type
article
Field-Weighted Citation Impact
2.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial

Nourdine Chakouri, Finn Gustafsson, Nir Y. Uriel, Ulrich P. Jorde et al.
4 citations
European Heart Journal
Mechanical Circulatory Support Devices
2.70
article

Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial

Nourdine Chakouri, Finn Gustafsson, Nir Y. Uriel, Ulrich P. Jorde, Daniel Zimpfer, Ashwin Ravichandran, Rebecca Cogswell, Manreet Kanwar, Nick Dirckx, Francis D. Pagani, Farooq H. Sheikh, Mandeep R. Mehra, Jennifer Conway, Jean M. Connors, Ivan Netuka, ERIC D. ADLER, Mirnela Byku, J. Ransom, Michael M. Givertz, Anita Phancao, Richa Agarwal, Jason N. Katz, Eugene Chung, Shelley Hall, Jonathan Grinstein, Hassan Nemeh
article en
4 citations

Abstract

The quality of VKA management as measured by TTR correlates with the occurrence of non-surgical bleeding in patients with the HM3 LVAD, with a lower TTR associated with an increased bleeding risk. These data provide new clinical direction to define a benchmark TTR to achieve further mitigation of residual risk of bleeding and enhance haemocompatibility with the HM3 LVAD.

European Heart JournalVol. 47(8)
University of North Carolina at Chapel Hill (US), Brigham and Women's Hospital (US), Albert Einstein College of Medicine (US), Allegheny Health Network (US), Montefiore Medical Center (US), University of Alberta (CA), Baylor University (US), Georgetown University (US), University of Michigan (US), Vanguard College (CA), St Vincent Hospital (US), American Orchid Society (US), UC San Diego Health System (US), Copenhagen University Hospital (DK), Rigshospitalet (DK), Henry Ford Hospital (US), University of Chicago (US), Abbott (United States) (US), Baptist Health Foundation (US), St. Vincent Hospital (US), Bellevue Hospital Center (US), Heart Hospital Baylor Plano (US), Montefiore Health System (US), Michigan Medicine (US), Duke Medical Center (US), Institute of Clinical and Experimental Medicine (CZ), Christ Hospital (US), University of Minnesota Medical Center (US), Abbott Fund (US), MedStar Heart & Vascular Institute (US), Baylor Jack and Jane Hamilton Heart and Vascular Hospital (US), Medical University of Vienna (AT), Columbia University (US)
Abbott Laboratories, Abiomed
Openalex Percentile: Top 9%
Mechanical Circulatory Support Devices
2.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.